Your Training Isn't Working Because It Isn't Yours.

ACTN3 encodes alpha-actinin-3, a structural protein that anchors the contractile machinery inside fast-twitch muscle fibers. Fast-twitch fibers are built for explosive power, speed, and anaerobic force. They’re what fires during a sprint, a heavy lift, or a quick directional change. ACTN3 is the scaffolding that holds that machinery together.

The problem is the X577 variant (often called the null variant), carried by roughly 18% of people of European ancestry. This variant produces no functional ACTN3 protein at all. Your fast-twitch fibers lack the structural support they need. You still have fast-twitch fibers, but they’re less forceful and less able to generate explosive power.

What this means practically: Your body isn’t built for maximum strength or speed. You won’t be a sprinter or a power lifter no matter how hard you train. But here’s the hidden advantage: without the fast-twitch bias, your slow-twitch endurance fibers dominate. Your aerobic capacity, sustained effort, and endurance sports are often your strength. You’re wired for the marathon, not the 100-meter dash.

PPARGC1A encodes PGC-1 alpha, often called the “master regulator of mitochondrial biogenesis.” When you do aerobic exercise, your muscles sense the energy demand and send signals to build more mitochondria, the energy-producing powerhouses inside your cells. More mitochondria means higher aerobic capacity, better oxygen utilization, and faster energy production during sustained effort. PGC-1 alpha is the molecule that translates the exercise signal into the instruction to build those mitochondria.

The Ser482 variant, present in roughly 35-40% of the population, impairs this signaling. Your muscles don’t receive the full “build mitochondria” message after aerobic training. You still get some adaptation, but significantly less than someone with the Gly allele. You do the same endurance training, but your mitochondrial density doesn’t increase as much.

What this means practically: Long, slow distance training produces less aerobic capacity gain for you than it does for others. A 12-week endurance program that increases VO2max by 15% in your training partner might only increase yours by 8-10%. You can still improve, but the return on aerobic training investment is lower. Your training needs to be more strategically intense, not just longer.

ADRB2 encodes the beta-2 adrenergic receptor, the primary sensor on fat cells that tells them to release stored energy during exercise. When you exercise, your body releases epinephrine and norepinephrine, two hormones that tell your fat cells to break down triglycerides and release them into the bloodstream as fuel. ADRB2 is the receptor that receives this signal. Without a working receptor, the message never reaches the fat cell.

Two common variants (Gln27Glu and Arg16Gly) reduce the receptor’s sensitivity to these hormones, present in roughly 40% of the population. Your fat cells don’t respond as forcefully to the “release energy” signal during exercise. Even when catecholamine levels are high, your adipose tissue just holds onto its stores.

What this means practically: You do the same cardio as someone else, but you mobilize less fat and burn fewer calories from fat stores. This makes body composition changes harder. The scale doesn’t move as easily. Your training partner gets leaner on steady-state cardio; you don’t. This isn’t a willpower issue. It’s a receptor sensitivity issue. You need a different approach to body composition.

VDR encodes the vitamin D receptor, a protein inside muscle cells that receives vitamin D signals. Vitamin D is required for muscle protein synthesis (building new muscle after training), calcium signaling (the mechanism that tells muscles to contract and recover), and the inflammatory response after exercise (the cleanup phase that determines how quickly you bounce back). Without working vitamin D receptors, your muscles can’t perform any of these processes efficiently.

Common VDR variants (BsmI and FokI), present in roughly 30-50% of people depending on variant, reduce the receptor’s ability to respond to vitamin D signaling. Even with adequate vitamin D levels in your blood, your muscle cells aren’t receiving the full signal to repair and rebuild. You have the raw material, but the receptor isn’t transducing it properly.

What this means practically: You recover slower between training sessions. Muscle soreness lasts longer. The window to stack another hard session is longer. Training adaptations take more time. You might need 72 hours between lower-body sessions instead of 48 hours. Muscle growth happens, but it’s slower. Injury recovery takes longer. This is especially frustrating because standard bloodwork shows your vitamin D levels as normal, so doctors tell you the problem isn’t vitamin D. But the problem isn’t your levels. It’s your receptor sensitivity.

SOD2 encodes superoxide dismutase 2, a mitochondrial antioxidant enzyme. When you exercise, especially intensely, your mitochondria produce reactive oxygen species (free radicals) as a byproduct of energy production. Some of this stress is beneficial; it triggers the adaptation response. But too much damages muscle cell membranes, impairs recovery, and prolongs soreness. SOD2 clears the excess, keeping oxidative stress in the productive range rather than the damaging range.

The Val16Ala variant, present in roughly 40% of people homozygously, produces less effective SOD2 enzyme. Your mitochondria generate the same amount of oxidative stress during exercise, but you clear it more slowly. Excess free radicals linger in your muscle tissue longer after training.

What this means practically: You experience more severe delayed-onset muscle soreness (DOMS). Recovery takes longer. High-volume training leaves you more damaged than it does others. Intense sessions need to be spaced further apart. You’re more sensitive to overtraining. You also can’t tolerate high-frequency training the way others can. If you’re doing 4 days of heavy lifting, you might only recover well from 3. Your training volume ceiling is lower.

MTHFR encodes methylenetetrahydrofolate reductase, the enzyme that activates folate into the form your cells can use for DNA synthesis and one-carbon metabolism. One of the most important uses of active folate is red blood cell production. Your bone marrow uses active folate to build new red blood cells constantly; red blood cells only live 120 days. Without adequate active folate, red blood cell production slows. You produce fewer red blood cells or they’re poorly formed.

The C677T variant, present in roughly 40% of people of European ancestry, reduces this enzyme’s activity by 40-70%. Your cells convert dietary folate into usable form slowly. Even with adequate folate intake, your functional folate status may be low. Red blood cell production slows. Homocysteine rises (a secondary consequence of impaired methylation).

What this means practically: You have less efficient oxygen transport. Your aerobic capacity is lower than you’d expect for your training. Your VO2max gains don’t match your effort. Intense exercise leaves you more fatigued because your blood oxygen-carrying capacity is compromised. The limiting factor isn’t your training stimulus. It’s your ability to deliver oxygen. Standard bloodwork might show normal folate and B12, but you’re functionally depleted at the cellular level.